So, despite the hype, there is now strong evidence that neither remdesivir nor hydroxychloroquine have any benefit for hospitalized patients with COVID-19
-
-
Show this thread
-
Moreover, there was no benefit found ~in any subgroup~. In this study, neither younger age nor more/less severe disease appeared to impact the drug workingpic.twitter.com/hWoYUljbo3
Show this thread
End of conversation
New conversation -
-
-
Once again WHO trial badly designed/ trying out a potential antiviral at late stage when the effect, if any, would be early in the disease... when the objective is to try and reduce viral load
-
It has been marketed and sold as a treatment in late stage disease, why would it be incorrect to test that?
End of conversation
New conversation -
-
-
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
No zinc was administered, the HCQ was given too late for any antiviral to have an effect and the they let in patients as young as 18 so of course most would show no benefit since they would be considered low risk.
-
Zinc is nonsense and does nothing to any corona virus infection. HCQ does nothing when given prophylacticly or given early.
End of conversation
New conversation -
-
-
Kind of thought interferon had a shot.
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
Check out James Reynold's research at Case Western using Ethyl Nitrite. Looks really promising
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
Good news for vaccine investor Bill Gates .
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.